SUMO1 Protein (Transcript Variant 2)
Quick Overview for SUMO1 Protein (Transcript Variant 2) (ABIN2732976)
Target
See all SUMO1 ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Protein Characteristics
- Transcript Variant 2
-
Characteristics
-
- Recombinant human SUMO1 (transcript variant 2) protein expressed in E. coli.
- Produced with end-sequenced ORF clone
-
Endotoxin Level
- < 0.1 EU per μg protein as determined by LAL test
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Restrictions
- For Research Use only
-
-
-
Buffer
- Lyophilized from a 0.2 μM filtered solution of 50 mM Tris-HCl, 100 mM NaCl, 1 mM DTT, pH 8.5. Stable for at least 6 months from date of receipt under proper storage and handling conditions.
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
-
Alternative Name
- Sumo1
-
Background
- This gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last four amino acids of the carboxy-terminus have been cleaved off. Several pseudogenes have been reported for this gene. Alternate transcriptional splice variants encoding different isoforms have been characterized.
-
Molecular Weight
- 13.7 kDa
-
NCBI Accession
- NP_001005781
-
Pathways
- M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
Target
-